Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled SNG001 in COPD patients with and without respiratory viral infection
2017-003679-75Phase 2Unknown
- Sponsor
- Synairgen
- Start
- Oct 2017
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) and Respiratory viral illness comparing SNG001 with Placebo (2 arms). Status: unknown.
02
Drugs
interferon beta-1a
03
Conditions
chronic obstructive pulmonary disease (COPD)Respiratory viral illness
Beyond the preview
Go deeper on 2017-003679-75.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-003679-75.